Woo E, Bredvik K, Liu B, Fuchs TJ, Manfredi G, Konrad C.  2023.  Machine learning approaches based on fibroblast morphometry do not predict ALS.. Neurobiol Aging. 130:80-83.

Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..  2017.  Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.

Boeynaems S, Bogaert E, Kovacs D, Konijnenberg A, Timmerman E, Volkov A, Guharoy M, De Decker M, Jaspers T, Ryan VH et al..  2017.  Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics.. Mol Cell. 65(6):1044-1055.e5.

Monahan Z, Ryan VH, Janke AM, Burke KA, Rhoads SN, Zerze GH, O'Meally R, Dignon GL, Conicella AE, Zheng W et al..  2017.  Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity.. EMBO J. 36(20):2951-2967.

Kim H-J, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM-Y, Finkbeiner S, Gitler AD, Bonini NM.  2014.  Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.. Nat Genet. 46(2):152-60.

Webster YW, Dow ER, Koehler J, Gudivada RC, Palakal MJ.  2011.  Leveraging health social networking communities in translational research.. J Biomed Inform. 44(4):536-44.

Di Giorgio FPaolo, Carrasco MA, Siao MC, Maniatis T, Eggan K.  2007.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.. Nat Neurosci. 10(5):608-14.